Meeting of the Advisory Commission on Childhood Vaccines

Federal Register, Volume 85 Issue 1 (Thursday, January 2, 2020)
[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
[Pages 112-113]
From the Federal Register Online via the Government Publishing Office []
[FR Doc No: 2019-28294]
Health Resources and Services Administration
Meeting of the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) will hold public meetings for the 2020 calendar year (CY).
Information about ACCV, agendas, and materials for these meetings can
be found on the ACCV website at
DATES: ACCV meetings will be held on:
     March 5-6, 2020;
     June 4-5, 2020;
     September 3-4, 2020; and
     December 3-4, 2020.
    These meetings will be held from 9:00 a.m.-5:00 p.m. Eastern Time.
ADDRESSES: Meetings may be held in-person, by teleconference, and/or
Adobe Connect webinar. In-person ACCV meetings will be held at 5600
Fishers Lane, Rockville, Maryland 20857. Instructions for joining the
meetings either in-person or remotely will be posted on the ACCV
website 30 business days before the date of the meeting. For meeting
[[Page 113]]
updates, go to the ACCV website at
FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury
Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville,
Maryland 20857; 301-443-6634; or [email protected].
SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations
to the Secretary of HHS on policy, program development, and other
issues related to implementation of the National Vaccine Injury
Compensation Program (VICP) and concerning other matters as described
under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
    Agenda items and meeting times are subject to change as priorities
dictate. Refer to the ACCV website listed above for any meeting updates
that may occur. For CY 2020 meetings, agenda items may include, but are
not limited to updates from: (1) The Division of Injury Compensation
Programs; (2) Department of Justice; (3) Office of Infectious Disease
and HIV/AIDS Policy (HHS); (4) Immunization Safety Office (Centers for
Disease Control and Prevention); (5) National Institute of Allergy and
Infectious Diseases (National Institutes of Health); and, (6) Center
for Biologics, Evaluation and Research (Food and Drug Administration).
Refer to the ACCV website listed above for all current and updated
information concerning the CY 2020 ACCV meetings, including draft
agendas and meeting materials that will be posted 5 calendar days
before the meeting.
    Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACCV should be sent
to Annie Herzog using the contact information above at least 5 business
days before the meeting date(s).
    Individuals who need special assistance or another reasonable
accommodation should notify Annie Herzog using the contact information
listed above at least 10 business days before the meeting(s) they wish
to attend. Since all in person meetings will occur in a federal
government building, attendees must go through a security check to
enter the building. Non-U.S. Citizen attendees must notify HRSA of
their planned attendance at least 20 business days prior to the meeting
in order to facilitate their entry into the building. All attendees are
required to present government-issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019-28294 Filed 12-31-19; 8:45 am]